Literature DB >> 29235009

Duodenal Exclusion but Not Sleeve Gastrectomy Preserves Insulin Secretion, Making It the More Effective Metabolic Procedure.

Claudia Laessle1,2, Gergana Nenova3, Goran Marjanovic3, Gabriel Seifert3, Lampros Kousoulas3, Bernd Jaenigen3, Stefan Fichtner-Feigl3, Jodok Matthias Fink3.   

Abstract

INTRODUCTION: There is an ongoing debate on which procedure provides the best treatment for type 2 diabetes. Furthermore, the pathomechanisms of diabetes improvement of partly anatomically differing operations is not fully understood.
METHODS: A loop duodenojejunostomy (DJOS) with exclusion of one third of intestinal length, a sleeve gastrectomy (SG), or a combination of DJOS + SG was performed in 8-week-old male ZDF rats. One, three, and six months after surgery, an oral glucose tolerance test and measurements of GLP-1, GIP, insulin, and bile acids were conducted.
RESULTS: After an initial (4 weeks) equal glucose control, DJOS and DJOS + SG showed significantly lower glucose levels than SG 3 and 6 months after surgery. There was sharp decline of insulin levels in SG animals over time, whereas insulin levels in DJOS and DJOS + SG were preserved. GIP levels were significantly larger in both groups containing a sleeve at all three time points, whereas GLP-1 was equal in all groups at all time. Bile acid levels were significantly higher in the DJOS compared to the SG group at all time points. Interestingly, the additional SG in the DJOS + SG group led to lower bile acid levels 1 and 6 months postoperatively.
CONCLUSION: The effect of SG on glucose control was transient, whereas a duodenal exclusion was the more effective procedure in this model due to a sustained pancreatic function with a preserved insulin secretion.

Entities:  

Keywords:  Diabetes mellitus; Duodenal exclusion; Gastric bypass; Insulin secretion; Sleeve gastrectomy

Mesh:

Substances:

Year:  2018        PMID: 29235009     DOI: 10.1007/s11695-017-3045-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  37 in total

1.  Can Sleeve Gastrectomy "Cure" Diabetes? Long-term Metabolic Effects of Sleeve Gastrectomy in Patients With Type 2 Diabetes.

Authors:  Ali Aminian; Stacy A Brethauer; Amin Andalib; Suriya Punchai; Jennifer Mackey; John Rodriguez; Tomasz Rogula; Matthew Kroh; Philip R Schauer
Journal:  Ann Surg       Date:  2016-10       Impact factor: 12.969

2.  The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats.

Authors:  Tammy L Kindel; Stephanie M Yoder; David A D'Alessio; Patrick Tso
Journal:  Obes Surg       Date:  2010-02-23       Impact factor: 4.129

Review 3.  Sleeve Gastrectomy and Type 2 Diabetes Mellitus: a Systematic Review of Long-Term Outcomes.

Authors:  Noah J Switzer; Shalvin Prasad; Estifanos Debru; Neal Church; Philip Mitchell; Richdeep S Gill
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

Review 4.  Intestinal bile acid receptors are key regulators of glucose homeostasis.

Authors:  Mohamed-Sami Trabelsi; Sophie Lestavel; Bart Staels; Xavier Collet
Journal:  Proc Nutr Soc       Date:  2016-11-16       Impact factor: 6.297

5.  Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery.

Authors:  Jie Chai; Guangyong Zhang; Shaozhuang Liu; Chunxiao Hu; Haifeng Han; Sanyuan Hu; Zongli Zhang
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

6.  GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.

Authors:  Jianping Ye; Zheng Hao; Michael B Mumphrey; R Leigh Townsend; Laurel M Patterson; Nicholas Stylopoulos; Heike Münzberg; Christopher D Morrison; Daniel J Drucker; Hans-Rudolf Berthoud
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-15       Impact factor: 3.619

7.  A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal-Jejunal Bypass on Type-2 Diabetes in non-Obese Rats.

Authors:  Bo Xu; Xiaojie Yan; Yikai Shao; Qiwei Shen; Rong Hua; Rui Ding; Qiyuan Yao
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

Review 8.  Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis.

Authors:  Jianfang Li; Dandan Lai; Dongping Wu
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

9.  Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.

Authors:  Charles Robb Flynn; Vance L Albaugh; Steven Cai; Joyce Cheung-Flynn; Phillip E Williams; Robert M Brucker; Seth R Bordenstein; Yan Guo; David H Wasserman; Naji N Abumrad
Journal:  Nat Commun       Date:  2015-07-21       Impact factor: 14.919

10.  Effect of Laparoscopic Sleeve Gastrectomy on Fasting Gastrointestinal, Pancreatic, and Adipose-Derived Hormones and on Non-Esterified Fatty Acids.

Authors:  John E Farey; Tamara C Preda; Oliver M Fisher; Angelique J Levert-Mignon; Rebecca L Stewart; Elisabeth Karsten; Benjamin R Herbert; Michael M Swarbrick; Reginald V Lord
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

View more
  3 in total

1.  Putting the Hindgut Hypothesis to the Test in a Diabetic Zucker Rat Model.

Authors:  Claudia Laessle; Ke Jin; Gabriel J Seifert; Sylvia Timme-Bronsert; Stefan Fichtner-Feigl; Goran Marjanovic; Jodok Matthias Fink
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

2.  Ileal interposition coupled with duodenal diverted sleeve gastrectomy versus standard medical treatment in type 2 diabetes mellitus obese patients: long-term results of a case-control study.

Authors:  Diego Foschi; Luca Sorrentino; Igor Tubazio; Consuelo Vecchio; Tarcisio Vago; Maurizio Bevilacqua; Andrea Rizzi; Fabio Corsi
Journal:  Surg Endosc       Date:  2018-09-17       Impact factor: 4.584

3.  Bariatric surgery and the neurohormonal switch: Early insulin resistance recordings after laparoscopic sleeve gastrectomy.

Authors:  Cheyaanthan Haran; Yu Kai Lim; Imad Aljanabi; Simon Bann; Susrutha Wickremesekera
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.